Lymph Tech
Developing mRNA gene therapies for patients with lymphedema and related lymphatic disorders
Highlights
- Young companyFounded 2024
- New on EvolcAdded 2026-11-09
About Lymph Tech
Lymph Tech is developing an mRNA-vector gene therapy using Apelin and VEGFC to regenerate the lymphatic system in lymphedematous limbs. The company describes its approach as non-integrative, designed for in-vivo delivery and easier production.
Its initial program targets patients who develop lymphedema after breast cancer; a Phase I/IIa clinical trial was planned to begin in 2025. The company is based in Pompertuzat, France, and was founded in 2024.
Product: An mRNA-vector gene therapy program using Apelin and VEGFC for lymphedema.
Jobs at Lymph Tech
More biotech & pharma companies
Lys Therapeutics
Biotech developing an antibody to treat blood-brain barrier dysfunction and neuroinflammation in neurological diseasesNew on EvolcMaat Pharma
Develops microbiome-based cancer therapeutics for patients with severe oncology diseasesNew on EvolcMabqi
Discovers and develops therapeutic antibodies for biopharmaceutical partners and oncology treatment programsNew on EvolcMabsilico
AI-based antibody candidate design for biotech and pharma companies, with candidates delivered in 21 daysNew on EvolcMatwin
Oncology innovation platform connecting early-stage cancer projects with industry, researchers and support programs in FranceNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Backend
- PHPHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerx-powered-by
Content management
- ElementorHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- ApacheHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.